Both North and South Dakota Could Legalize Marijuana This November: A Look at the Two Initiatives

As November approaches, both North and South Dakota find themselves at pivotal moments in their respective paths toward marijuana legalization.

Voters in both states will have the opportunity to decide on measures that would legalize recreational marijuana for everyone 21 and older.

In North Dakota, Measure 5 would allow for the possession and use of up to one ounce of marijuana, four grams of marijuana concentrates, 1,500mg of THC in the form of cannabinoid products, and 300mg of edibles.
Continue reading

VA Medicinal Cannabis Research Act Gains 21st Sponsors in US Congress

The VA Medicinal Cannabis Research Act, legislation that seeks to advance research into the potential benefits of medical cannabis for veterans, has gained its 21st sponsor in the U.S. Congress.

On August 9, Congressmember Jason Crow (D-CO) signed on as a cosponsor of the House version of the bill, bringing the total number of sponsors in the US House of Representatives to 12. The Senate version of the bill currently has 12 sponsors, making for a combined total of 21 supporters in Congress. Congressmember Zoe Lofgren (D-CA) was the most recent new cosponsor prior to Crow. Lofgren signed on July 9.

The bill, introduced by Congressmember Lou Correa (D-CA) in the House (H.R. 1003) and by Senator Jon Tester (D-MT) in the Senate (S. 326), mandates the Department of Veterans Affairs (VA) to conduct clinical trials on the safety and efficacy of cannabis in treating veterans diagnosed with conditions such as chronic pain and post-traumatic stress disorder (PTSD). The legislation would also require the VA to submit reports on its findings to Congress, paving the way for informed policy decisions based on empirical evidence.
Continue reading

Teamsters Unionize 10th Marijuana Store in Illinois

Teamsters have successfully unionized their 10th marijuana store in Illinois.

teamsters 777Earlier this week, Teamsters Local 777 announced that they’ve won both a new collective bargaining agreement and an election at Zen Leaf in less than one week. Zen Leaf is a subsidiary of the multi-state operator Verano Holdings.

This accomplishment is the fourth Verano store in Illinois to unionize under the Teamsters. The push for unionization has been gaining momentum across the state in recent months, with six other Illinois cannabis stores voting to unionize earlier this year, bringing the total unionized marijuana stores in the state to at least 10.
Continue reading

Study: Nightly CBD Use for Insomnia Found Safe, Preserves Daytime Cognitive Function

A new study published in the journal Psychopharmacology shows that cannabidiol (CBD) may be useful as a sleep aid for individuals suffering from insomnia.

Conducted by researchers from Swinburne University of Technology and the Institute for Breathing and Sleep at Austin Hospital, the randomized controlled pilot trial explored whether nightly use of CBD impacts daytime neurocognitive performance. The study was published online ahead of print by the US National Library of Medicine.

The study involved 30 participants with primary insomnia, who were randomly assigned to receive either 150 mg of CBD or a placebo each night for two weeks. Before the double-blind dosing period, a single-blind placebo run-in week was conducted. The researchers assessed various cognitive functions, including attention, executive function, reasoning, information processing, and memory, using the CogPro system. These assessments were performed at the start of the trial, after one week, and at the trial’s conclusion.
Continue reading

Clinical Trial Finds Marijuana Capsules Effective in Reducing Chemotherapy-Induced Nausea and Vomiting

A new study published in the Journal of Clinical Oncology reveals that marijuana capsules containing both tetrahydrocannabinol (THC) and cannabidiol (CBD) significantly reduces chemotherapy-induced nausea and vomiting in patients who have not responded to standard antiemetic treatments.

Marijuana capsules.

This randomized, placebo-controlled, phase II/III trial, conducted across 19 hospitals and universities in Australia, is one of the most comprehensive studies to date on the subject.

The study aimed to assess the efficacy of THC capsules as an adjunct treatment for adults suffering from nausea and vomiting during moderately or highly emetogenic chemotherapy, despite receiving guideline-consistent antiemetic prophylaxis. The trial included 147 participants who were given either the THC capsules or a placebo, in addition to their standard antiemetic medication during the first cycle of chemotherapy.
Continue reading

Vermont Recorded Over $66 Million in Marijuana Sales in First Half of 2024, Nearly $10 Million in Taxes

Vermont’s legal marijuana market generated over $66 million in revenue between January and June of this year.

(Photo credit: USA Today).

In the first half of 2024, Vermont’s licensed marijuana stores sold $66.22 million worth of marijuana and marijuana products, resulting in approximately $8.5 million in tax revenue, according to data compiled and released by the Vermont Department of Taxes.

The monthly high for the year was in May, with $11.45 million in sales generating $1.60 million in taxes. June followed with $11.14 million in sales, resulting in $1.56 million in tax revenue.”

Continue reading

DEA Official: Marijuana Set to be Rescheduled by October, Thousands of Comments Already Analyzed

The Drug Enforcement Administration (DEA) remains on track to finalize the rescheduling of marijuana by October, according to an agency official.

The public comment period for the proposed rescheduling ended on July 22, with over 43,000 comments submitted. The DEA is currently analyzing these comments, with a final ruling anticipated within the coming weeks.

The proposal to move marijuana to Schedule III was first published by the DEA on May 21, initiating a 60-day public comment period. With that period now concluded, the DEA’s focus has shifted to reviewing every comment, as required by law. According to the DEA official, this process is progressing as planned, despite the volume of comments.
Continue reading

Mike Tyson Backs Florida’s Amendment 3 to Legalize Recreational Marijuana

Legendary boxer Mike Tyson has announced his support for Florida’s Amendment 3, which would make recreational marijuana a constitutional right.

(Photo credit: 303 Magazine).

This week, Tyson released a video supporting Amendment 3, a ballot initiative that would allow those 21+ in Florida to legally purchase, possess, and consume marijuana. Sitting in a boxing gym, Tyson addressed Florida voters directly, urging them to back the amendment.

“Florida voters, this is Mike Tyson, urging you to support Amendment 3,” Tyson said in the video. “Like most of you, I support the freedom to buy, possess, and consume marijuana without the threat of being incarcerated. So, yes! Vote Amendment 3. Now.”
Continue reading

California Committee Approves House-Backed Bill to Allow Growers to Sell Marijuana at Farmers Markets

A key committee in the California Legislature has passed legislation (Assembly Bill 1111) that would enable marijuana growers to sell their products directly to consumers at state-sanctioned farmers markets and other temporary events.

The legislation, introduced by Assemblymember Gail Pellerin (D), received unanimous approval from the Senate Appropriations Committee yesterday, with the voting being 4 to 0. In May 2023, the measure was passed through the state’s Assembly by a vote of 74 to 1. It was subsequently approved through two Senate committees later that year.

Now that the proposal has been passed through the Senate Appropriations Committee, it can be considered by the full Senate. If it passes the Senate, it will be sent back to the Assembly for one final vote given it was amended in committee. If it passes the Senate, and the Assembly concurs with changes, it will be sent to Governor Gavin Newsom for final consideration.
Continue reading

Medical Marijuana Now Legal in Ukraine

Legislation legalizing medical marijuana in Ukraine officially takes effect today.

In February, President Zelenskyy signed the legislation into law, following approval through the nation’s Verkhovna Rada with 248 of the body’s 450 members voting in favor.

Under the new law, which moves marijuana from the most prohibitive Schedule I list of drugs to Schedule II, those with a qualifying condition who receive a recommendation from a physician are authorized to possess and use medical marijuana. Although the law at the time of passage only applies to severe illness like cancer as well as war-borne post traumatic stress disorder (PTSD), proponents of the measure have said that the country can expand the list of qualifying conditions once it’s passed.
Continue reading